Generate a tailored SOP for Dr. Jeffrey Dunn. Improve your application with a focused, well-structured draft.
Jeffrey Dunn serves as the Lily Sarafan Director of Neuroimmunology and a Clinical Professor in the Department of Neurology & Neurological Sciences at Stanford University. His expertise lies in the diagnosis, treatment, and research concerning immune-mediated diseases of the central nervous system, particularly Multiple Sclerosis (MS), transverse myelitis, and Neuromyelitis Optica. Dr. Dunn is a widely recognized leader in the field, having been elected as a Fellow of the American Academy of Neurology and serving as past Chair of the MS Section of the AAN. With experience as Principal Investigator on over 30 clinical trials, he has significantly contributed to the development of new immunotherapies for MS, particularly focusing on cellular immune therapies. A key player in the Project BIG initiative at Stanford, Dr. Dunn collaborates with scientists to explore biomarkers and therapeutic targets in precision medicine. His work has led to notable discoveries, including findings on the role of EBV in MS pathogenesis, which earned him recognition as a runner-up for the Science Breakthrough Year 2022 by the American Association for the Advancement of Science. He has authored and co-authored over 50 peer-reviewed publications and has received numerous teaching awards, reflecting his commitment to clinical education in neurology.
Stanford University • Palo Alto, CA
Leads clinical and research initiatives in neuroimmunology.
Department of Neurology & Neurological Sciences • Stanford University
Directs research and clinical practice in neuroimmunology.
Department of Neurology & Neurological Sciences • Stanford University
Oversees division's clinical and research efforts.
Patent for a marker that determines patient's responsiveness to treatments.
The Computer Science department emphasizes research potential. GRE General is currently optional but recommended for some tracks.